Zentek Launches National Sampling Program for ZenGUARD(TM) Antimicrobial Surgical Masks

Rhea-AI Summary

Zentek (NASDAQ:ZTEK, TSXV:ZEN) has announced a nationwide sampling program for its ZenGUARD™ Antimicrobial Surgical Masks in Canada, facilitated by Henry Schein Inc. The program targets dental professionals, with ZenGUARD™ masks to be included in product shipments to Henry Schein customers.

Key features of ZenGUARD™ masks include:

• Enhanced protection against infectious agents
• 99.9% elimination of bacteria
• Reduction of mask-related acne
• Superior filtration compared to standard ASTM Level 3 surgical masks

Zentek CEO Greg Fenton emphasized the importance of safety in dental practices and positioned ZenGUARD™ technology as the new standard for protection in this market segment.

Positive

• Launch of nationwide sampling program for ZenGUARD™ Antimicrobial Surgical Masks
• Partnership with Henry Schein Inc. for product distribution
• Potential exposure to nearly all Henry Schein customers across Canada
• Superior product features compared to standard ASTM Level 3 surgical masks

Negative

• None.

Insights

Market Research Analyst

The partnership with Henry Schein Inc. to distribute ZenGUARD™ Antimicrobial Surgical Masks across Canada is a strategic move for Zentek. Henry Schein is a well-established distributor in the dental industry, which means this initiative could significantly increase the market penetration of ZenGUARD™ masks. This distribution strategy can help Zentek rapidly scale its product exposure and adoption. For retail investors, it’s essential to note that securing a partnership with a major distributor like Henry Schein could potentially lead to increased sales and revenue if the product gains traction in the market.

Medical Research Analyst

ZenGUARD™ Antimicrobial Surgical Masks have a unique value proposition with their ability to eliminate 99.9% of bacteria, which is a significant advantage over standard masks. This feature is particularly relevant in medical and dental settings where long-term mask wear is common. The claim that these masks can reduce mask-related acne could appeal to dental professionals and patients alike. From a clinical perspective, if these claims are backed by strong scientific evidence, it could lead to widespread adoption among healthcare providers, thereby boosting Zentek’s market share in the medical supplies sector.

Financial Analyst

This move could have positive financial implications for Zentek. By partnering with Henry Schein, a major distributor, Zentek is leveraging an established network to reach a broader audience. If the masks are well-received, it could result in significant revenue growth. Additionally, successful adoption in Canada could serve as a proof-of-concept for launching similar programs in other countries, potentially expanding Zentek’s market further. Investors should keep an eye on sales figures in the coming quarters to gauge the success of this initiative and its impact on Zentek’s financial performance.

GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. ("Henry Schein") that will see ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers.

In addition to offering dental practitioners and their patients a surgical mask with better protection against infectious agents, ZenGUARD™ Antimicrobial Surgical Masks are also proven to eliminate 99.9% of bacteria, which can collect on the skin when wearing a surgical mask for extended periods and cause acne. The Company believes this program will introduce ZenGUARD™ Antimicrobial Surgical Masks and this unique value proposition to nearly all Henry Schein customers across Canada.

"The safety of staff and patients in dental practices is paramount, and surgical masks play a crucial role as they serve as a primary barrier against the transmission of infectious agents, including bacteria, viruses, and other pathogens. With the ability for ZenGUARD™ Antimicrobial Surgical Masks to eliminate bacteria and filter more virus particles compared to standard ASTM Level 3 surgical masks, we believe that this technology should be the new standard of protection for this incredibly important market segment," said Greg Fenton, Zentek CEO.

About Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.

Zentek's patented technology platform ZenGUARD™, is shown to have 99-per-cent anti-microbial activity and to significantly increase the viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is in Guelph, Ontario.

For further information on Zentek:
investorrelations@zentek.com

Ryan Shacklock
Senior VP, Strategy & Business Development
Email: rshacklock@zentek.com
Phone: 306-270-9610

To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.

Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Zentek

View the original press release on accesswire.com

FAQ

What is Zentek's new product sampling program for ZenGUARD™ Antimicrobial Surgical Masks?

Zentek is launching a Canada-wide sampling program for dental professionals, facilitated by Henry Schein Inc., where ZenGUARD™ Antimicrobial Surgical Masks will be included in product shipments to Henry Schein customers.

What are the key features of Zentek's ZenGUARD™ Antimicrobial Surgical Masks?

ZenGUARD™ Antimicrobial Surgical Masks offer better protection against infectious agents, eliminate 99.9% of bacteria, reduce mask-related acne, and provide superior filtration compared to standard ASTM Level 3 surgical masks.

How does Zentek (ZTEK) plan to introduce ZenGUARD™ masks to the dental market?

Zentek is partnering with Henry Schein Inc. to include ZenGUARD™ Antimicrobial Surgical Masks in product shipments to Henry Schein customers, potentially reaching nearly all of their customers across Canada.

What advantage does Zentek (ZTEK) claim ZenGUARD™ masks have over standard surgical masks?

Zentek claims that ZenGUARD™ Antimicrobial Surgical Masks can eliminate more bacteria and filter more virus particles compared to standard ASTM Level 3 surgical masks, offering enhanced protection for dental professionals and patients.